[1] Arroyo V, Moreau R, Kamath PS, et al. Acute-on-chronic liver failure in cirrhosis. Nat Rev Dis Primers,2016,2:16041.
[2] Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology,2013,144:1426-1437.e9.
[3] Bajaj JS, O'Leary JG, Reddy KR, et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology,2014,60:250-256.
[4] Shi Y, Yang Y, Hu Y, et al. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology,2015,62:232-242.
[5] Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut,2018,67:2181-2191.
[6] Bernardi M, Moreau R, Angeli P, et al. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol,2015,63:1272-1284.
[7] Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol,2014,60:197-209.
[8] Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol,2015,16:343-353.
[9] Du Plessis J, Vanheel H, Janssen CE, et al. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J Hepatol,2013,58:1125-1132.
[10] Albillos A, Lario M, Alvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol,2014,61:1385-1396.
[11] Giron-Gonzalez JA, Martinez-Sierra C, Rodriguez-Ramos C, et al. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int,2004,24:437-445.
[12] Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science,2012,335:936-941.
[13] Claria J, Stauber RE, Coenraad MJ, et al. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure. Hepatology,2016,64:1249-1264.
[14] Bernsmeier C, Pop OT, Singanayagam A, et al. Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK. Gastroenterology,2015,148:603-615.e14.
[15] Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology,2006,43:S54-62.
[16] Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol,2009,27:147-163.
[17] Tritto G, Bechlis Z, Stadlbauer V, et al. Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J Hepatol,2011,55:574-581.
[18] Seidler S, Zimmermann HW, Weiskirchen R, et al. Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes. BMC Gastroenterol,2012,12:38.
[19] Bajaj JS, Moreau R, Kamath PS, et al. Acute-on-chronic liver failure: getting ready for prime time? Hepatology,2018,68:1621-1632.
[20] Albillos A, Hera Ad Ade L, Reyes E, et al. Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin. J Hepatol,2004,40:624-631.
[21] Munoz L, Jose Borrero M, Ubeda M, et al. Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis. Hepatology,2012,56:1861-1869. |
